Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Intensive Care Units in India (INDICAPS)

This study has been completed.
Sponsor:
Information provided by:
Indian Society of Critical Care Medicine
ClinicalTrials.gov Identifier:
NCT01384929
First received: June 28, 2011
Last updated: NA
Last verified: April 2011
History: No changes posted

June 28, 2011
June 28, 2011
July 2010
May 2011   (final data collection date for primary outcome measure)
All cause mortality [ Time Frame: 30-days ] [ Designated as safety issue: No ]
Same as current
No Changes Posted
  • ICU Length of stay [ Time Frame: 30 days ] [ Designated as safety issue: No ]
    Stay in ICU till 30 days
  • Hospital length of stay [ Time Frame: 30 days ] [ Designated as safety issue: No ]
    Stay in hospital till 30 days
  • Hospital survival [ Time Frame: 30 days ] [ Designated as safety issue: No ]
    Survival at hospital discharge or at 30 days
Same as current
Not Provided
Not Provided
 
Study of Intensive Care Units in India
Indian Intensive Care Case Mix and Practice Patterns Study

There is scant data on the casemix and practices in Indian intensive care units (ICUs). Most of the available data comes from single centre studies. There is a dire need to have data from Indian ICUs to reflect the vast spectrum of critical care illness, services and practices. INDICAPS planned to collect data of all patients in the ICU on one particular day, and four such days spread throughout a one-year period were selected: the second Wednesday of July and October this year, i.e. July 14 and October 13, 2010 and the second Wednesday of January and April next year, i.e. January 12 and April 13, 2011. As many ICUs all over the country as possible were asked to participate. The investigators aimed to gather information about ICUs, patients in ICUs, the types and severity of illness, monitoring and therapeutic modalities used, types of infections,mortality rates, etc.

The following information will be analysed:

Case-mix, severity of illness, prevalence of infection, hemodynamic monitoring and therapy, mechanical ventilation practices, nutrition and outcome

  • Seasonal and regional variations in the above
  • Epidemiology and variations in antibiotic use
  • Patterns of microorganisms and outcome
  • Prevalence and outcome of specific tropical febrile illnesses, including malaria, dengue fever, leptospirosis, scrub typhus
  • Prevalence and outcome of toxins and poisonings
  • Relation of ICU and hospital organizational issues to prevalence of infection and outcome
  • Organisation of intensive care services
  • End of life - Ethical decisions
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

All patients present in the ICU July 14, 2010, October 13, 2010, January 12, 2011 and April 13, 2011

Critical Illness
Not Provided
ICU patients
All patients present in the ICU on the selected days
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4236
May 2011
May 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All patients present in the ICU July 14, 2010, October 13, 2010, January 12, 2011 and April 13, 2011
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
India
 
NCT01384929
ISCCM01
No
JV Divatia / Chairman, Clinical Research, Dr. Rajesh Chawla, President, Indian Society of Critical Care Medicine
Indian Society of Critical Care Medicine
Not Provided
Study Chair: Jigeeshu Divatia, MD Indian Society of Critical Care Medicine
Indian Society of Critical Care Medicine
April 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP